The safety of whey protein concentrate derived from the milk of cows immunized against Clostridium difficile

Karen W.H. Young, Ian C. Munro, Steve L. Taylor, Peter Veldkamp, Jaap T. van Dissel

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

A whey protein concentrate prepared from the milk of cows that have been immunized against Clostridium difficile (C. difficile) and its toxins, toxin A and toxin B, is produced for use as a medical food for the dietary management of patients with C. difficile-associated diarrhea (CDAD) to prevent a relapse of the infection. The safety of anti-C. difficile whey protein concentrate (anti-CD WPC) is supported by analytical data comparing the composition of raw milk from immunized cows versus that from non-immunized cows, and the composition of anti-CD WPC versus that of regular whey protein concentrate. Additionally, a prospective clinical study was conducted in 77 patients with CDAD to demonstrate the safety of consuming anti-CD WPC to prevent relapse of the infection. This study, which included adverse event monitoring, physical examinations, and extensive hematological and biochemical assessments, showed that anti-CD WPC is safe to consume by patients with CDAD. The available analytical and clinical evidence demonstrate that anti-CD WPC is safe for use by individuals with CDAD, under the described conditions of use.

Original languageEnglish (US)
Pages (from-to)317-326
Number of pages10
JournalRegulatory Toxicology and Pharmacology
Volume47
Issue number3
DOIs
StatePublished - Apr 1 2007

Fingerprint

Clostridium
Clostridium difficile
Milk
Safety
Proteins
Diarrhea
Whey Proteins
Chemical analysis
Recurrence
Infection
Physical Examination
Monitoring
Prospective Studies
Food

Keywords

  • Bovine
  • Clostridium difficile
  • Hyperimmune milk
  • Immunoglobulin
  • Whey protein concentrate

ASJC Scopus subject areas

  • Toxicology

Cite this

The safety of whey protein concentrate derived from the milk of cows immunized against Clostridium difficile. / Young, Karen W.H.; Munro, Ian C.; Taylor, Steve L.; Veldkamp, Peter; van Dissel, Jaap T.

In: Regulatory Toxicology and Pharmacology, Vol. 47, No. 3, 01.04.2007, p. 317-326.

Research output: Contribution to journalArticle

Young, Karen W.H. ; Munro, Ian C. ; Taylor, Steve L. ; Veldkamp, Peter ; van Dissel, Jaap T. / The safety of whey protein concentrate derived from the milk of cows immunized against Clostridium difficile. In: Regulatory Toxicology and Pharmacology. 2007 ; Vol. 47, No. 3. pp. 317-326.
@article{30bad9e4994f47eaacc4eef61bb389d1,
title = "The safety of whey protein concentrate derived from the milk of cows immunized against Clostridium difficile",
abstract = "A whey protein concentrate prepared from the milk of cows that have been immunized against Clostridium difficile (C. difficile) and its toxins, toxin A and toxin B, is produced for use as a medical food for the dietary management of patients with C. difficile-associated diarrhea (CDAD) to prevent a relapse of the infection. The safety of anti-C. difficile whey protein concentrate (anti-CD WPC) is supported by analytical data comparing the composition of raw milk from immunized cows versus that from non-immunized cows, and the composition of anti-CD WPC versus that of regular whey protein concentrate. Additionally, a prospective clinical study was conducted in 77 patients with CDAD to demonstrate the safety of consuming anti-CD WPC to prevent relapse of the infection. This study, which included adverse event monitoring, physical examinations, and extensive hematological and biochemical assessments, showed that anti-CD WPC is safe to consume by patients with CDAD. The available analytical and clinical evidence demonstrate that anti-CD WPC is safe for use by individuals with CDAD, under the described conditions of use.",
keywords = "Bovine, Clostridium difficile, Hyperimmune milk, Immunoglobulin, Whey protein concentrate",
author = "Young, {Karen W.H.} and Munro, {Ian C.} and Taylor, {Steve L.} and Peter Veldkamp and {van Dissel}, {Jaap T.}",
year = "2007",
month = "4",
day = "1",
doi = "10.1016/j.yrtph.2006.12.001",
language = "English (US)",
volume = "47",
pages = "317--326",
journal = "Regulatory Toxicology and Pharmacology",
issn = "0273-2300",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - The safety of whey protein concentrate derived from the milk of cows immunized against Clostridium difficile

AU - Young, Karen W.H.

AU - Munro, Ian C.

AU - Taylor, Steve L.

AU - Veldkamp, Peter

AU - van Dissel, Jaap T.

PY - 2007/4/1

Y1 - 2007/4/1

N2 - A whey protein concentrate prepared from the milk of cows that have been immunized against Clostridium difficile (C. difficile) and its toxins, toxin A and toxin B, is produced for use as a medical food for the dietary management of patients with C. difficile-associated diarrhea (CDAD) to prevent a relapse of the infection. The safety of anti-C. difficile whey protein concentrate (anti-CD WPC) is supported by analytical data comparing the composition of raw milk from immunized cows versus that from non-immunized cows, and the composition of anti-CD WPC versus that of regular whey protein concentrate. Additionally, a prospective clinical study was conducted in 77 patients with CDAD to demonstrate the safety of consuming anti-CD WPC to prevent relapse of the infection. This study, which included adverse event monitoring, physical examinations, and extensive hematological and biochemical assessments, showed that anti-CD WPC is safe to consume by patients with CDAD. The available analytical and clinical evidence demonstrate that anti-CD WPC is safe for use by individuals with CDAD, under the described conditions of use.

AB - A whey protein concentrate prepared from the milk of cows that have been immunized against Clostridium difficile (C. difficile) and its toxins, toxin A and toxin B, is produced for use as a medical food for the dietary management of patients with C. difficile-associated diarrhea (CDAD) to prevent a relapse of the infection. The safety of anti-C. difficile whey protein concentrate (anti-CD WPC) is supported by analytical data comparing the composition of raw milk from immunized cows versus that from non-immunized cows, and the composition of anti-CD WPC versus that of regular whey protein concentrate. Additionally, a prospective clinical study was conducted in 77 patients with CDAD to demonstrate the safety of consuming anti-CD WPC to prevent relapse of the infection. This study, which included adverse event monitoring, physical examinations, and extensive hematological and biochemical assessments, showed that anti-CD WPC is safe to consume by patients with CDAD. The available analytical and clinical evidence demonstrate that anti-CD WPC is safe for use by individuals with CDAD, under the described conditions of use.

KW - Bovine

KW - Clostridium difficile

KW - Hyperimmune milk

KW - Immunoglobulin

KW - Whey protein concentrate

UR - http://www.scopus.com/inward/record.url?scp=33947140483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947140483&partnerID=8YFLogxK

U2 - 10.1016/j.yrtph.2006.12.001

DO - 10.1016/j.yrtph.2006.12.001

M3 - Article

C2 - 17293018

AN - SCOPUS:33947140483

VL - 47

SP - 317

EP - 326

JO - Regulatory Toxicology and Pharmacology

JF - Regulatory Toxicology and Pharmacology

SN - 0273-2300

IS - 3

ER -